{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T05:49:21Z","timestamp":1777268961150,"version":"3.51.4"},"reference-count":15,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T00:00:00Z","timestamp":1777248000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Hermansky\u2013Pudlak syndrome (HPS) is a rare autosomal recessive disorder characterized by oculocutaneous albinism (OCA), ocular nystagmus, bleeding diathesis and, in certain forms, pulmonary fibrosis (PF). We report a case of genetically confirmed HPS type 1 (HPS-1) with pulmonary involvement in a patient with rheumatoid arthritis (RA).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Patient concerns and clinical findings<\/jats:title>\n                    <jats:p>A 62-year-old Caucasian woman, former smoker, was referred for progressive pulmonary fibrosis (PPF) documented since 2019. History included chronic kidney disease and RA diagnosed in 2022, treated with hydroxychloroquine, prednisone, and abatacept. On presentation, she exhibited exertional dyspnea. Distinctive features included OCA, ocular nystagmus, and recurrent non-traumatic bruises, consistent with a bleeding tendency.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Diagnostic assessment<\/jats:title>\n                    <jats:p>Between 2021 and 2024, spirometry documented a decline in forced vital capacity - percent of predicted (FVC%) from 86% to 61% and a reduction in diffusing capacity of carbon monoxide - percent of predicted (DLCO%) from 60% to 37%. The six-minute walking test (6MWT) revealed exertional desaturation. High-resolution computed tomography (HRCT) showed PPF characterized by reticular thickening, ground-glass opacities (GGO), honeycombing, and traction bronchiectasis. Platelet aggregation study revealed impaired function with reduced CD41a expression, while transmission electron microscopy (TEM) confirmed rarefaction-to-absence of platelet dense granules. Genetic analysis identified a homozygous c.355del p.(His119ThrfsTer5) pathogenic variant in HPS1, confirming HPS-1.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Interventions and outcomes<\/jats:title>\n                    <jats:p>Abatacept was discontinued and rituximab initiated for RA management. Antifibrotic therapy was not pursued due to renal impairment and limited supporting evidence. Supportive measures included supplemental oxygen during exertion, pulmonary rehabilitation, and vaccination. Lung transplantation was deemed infeasible owing to renal failure and active autoimmune disease. The patient remains under follow-up.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>In patients presenting with PF, OCA, and bleeding diathesis, HPS should be suspected. Diagnostic workup begins with platelet aggregation study and TEM of platelets, and the diagnosis is confirmed by molecular genetic testing. No disease-modifying therapies exist for HPS-associated PF (HPS-PF); pirfenidone has uncertain benefit, while lung transplantation remains the only option for end-stage disease. This case underscores the need for early suspicion of HPS to guide investigations, counseling, and referral to specialized care. Moreover, the unusual association with RA is emphasized, as it may have contributed to PF.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2026.1778211","type":"journal-article","created":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T05:27:10Z","timestamp":1777267630000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Case Report: Hermansky\u2013Pudlak syndrome type 1 with pulmonary involvement in a 62-year-old Caucasian woman with rheumatoid arthritis"],"prefix":"10.3389","volume":"17","author":[{"given":"Giacomo","family":"Giulianelli","sequence":"first","affiliation":[{"name":"Respiratory Disease Unit, University Hospital","place":["Padua, Italy"]},{"name":"Department of Cardiac, Thoracic, Vascular Sciences and Public Health; University of Padua","place":["Padua, Italy"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicol","family":"Bernardinello","sequence":"additional","affiliation":[{"name":"Respiratory Disease Unit, University Hospital","place":["Padua, Italy"]},{"name":"Department of Cardiac, Thoracic, Vascular Sciences and Public Health; University of Padua","place":["Padua, Italy"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisabetta","family":"Cocconcelli","sequence":"additional","affiliation":[{"name":"Respiratory Disease Unit, University Hospital","place":["Padua, Italy"]},{"name":"Department of Cardiac, Thoracic, Vascular Sciences and Public Health; University of Padua","place":["Padua, Italy"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefania","family":"Rizzo","sequence":"additional","affiliation":[{"name":"Department of Cardiac, Thoracic, Vascular Sciences and Public Health; University of Padua","place":["Padua, Italy"]},{"name":"Cardiovascular Pathology Unit, University Hospital","place":["Padua, Italy"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina","family":"Basso","sequence":"additional","affiliation":[{"name":"Department of Cardiac, Thoracic, Vascular Sciences and Public Health; University of Padua","place":["Padua, Italy"]},{"name":"Cardiovascular Pathology Unit, University Hospital","place":["Padua, Italy"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonella","family":"Bertomoro","sequence":"additional","affiliation":[{"name":"Department of Medicine DIMED, Padova University Hospital","place":["Padova, Italy"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvia","family":"Ferrari","sequence":"additional","affiliation":[{"name":"Department of Medicine DIMED, Padova University Hospital","place":["Padova, Italy"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Davide","family":"Colavito","sequence":"additional","affiliation":[{"name":"R&I Genetics s.r.l.","place":["Padua, Italy"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paolo","family":"Spagnolo","sequence":"additional","affiliation":[{"name":"Respiratory Disease Unit, University Hospital","place":["Padua, Italy"]},{"name":"Department of Cardiac, Thoracic, Vascular Sciences and Public Health; University of Padua","place":["Padua, Italy"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisabetta","family":"Balestro","sequence":"additional","affiliation":[{"name":"Respiratory Disease Unit, University Hospital","place":["Padua, Italy"]},{"name":"Department of Cardiac, Thoracic, Vascular Sciences and Public Health; University of Padua","place":["Padua, Italy"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,4,27]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1513\/AnnalsATS.201603-186FR","article-title":"Pulmonary fibrosis in Hermansky-Pudlak syndrome","volume":"13","author":"Vicary","year":"2016","journal-title":"Ann Am Thorac Soc"},{"key":"B2","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1111\/pcmr.13030","article-title":"New insights into the pathogenesis of Hermansky\u2013Pudlak syndrome","volume":"35","author":"Li","year":"2022","journal-title":"Pigment Cell Melanoma Res"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1002\/art.27584","article-title":"Rheumatoid arthritis classification criteria: An American College of Rheumatology\/European League Against Rheumatism collaborative initiative","volume":"62","author":"Aletaha","year":"2010","journal-title":"Arthritis Rheum"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1055\/s-0030-1249628","article-title":"Compound heterozygous mutations in 2 siblings with Hermansky-Pudlak syndrome type 1 (HPS1)","volume":"222","author":"Sandrock","year":"2010","journal-title":"Klin Padiatr"},{"key":"B5","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1160\/TH14-11-0999","article-title":"A review of platelet secretion assays for the diagnosis of inherited platelet secretion disorders","volume":"114","author":"Mumford","year":"2015","journal-title":"Thromb Haemost"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0194193","article-title":"Clinical management and outcomes of patients with Hermansky-Pudlak syndrome pulmonary fibrosis evaluated for lung transplantation","volume":"13","author":"El-Chemaly","year":"2018","journal-title":"PloS One"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1002\/iub.70025","article-title":"Hermansky-Pudlak syndrome: From molecular pathogenesis to targeted therapies","volume":"77","author":"Tondi","year":"2025","journal-title":"IUBMB Life"},{"key":"B8","doi-asserted-by":"publisher","first-page":"59","DOI":"10.4103\/2156-7514.143437","article-title":"Hermansky-Pudlak syndrome complicated by pulmonary fibrosis: Radiologic-pathologic correlation and review of pulmonary complications","volume":"4","author":"Kelil","year":"2014","journal-title":"J Clin Imaging Sci"},{"key":"B9","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1164\/ajrccm.165.2.ats01","volume":"165","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/S1096-7192(02)00044-6","article-title":"Effect of pirfenidone on the pulmonary fibrosis of Hermansky\u2013Pudlak syndrome","volume":"76","author":"Gahl","year":"2002","journal-title":"Mol Genet Metab"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymgme.2018.07.012","article-title":"Prolonged treatment with open-label pirfenidone in Hermansky-Pudlak syndrome pulmonary fibrosis","volume":"125","author":"O\u2019Brien","year":"2018","journal-title":"Mol Genet Metab"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymgme.2011.02.003","article-title":"Pirfenidone for the treatment of Hermansky\u2013Pudlak syndrome pulmonary fibrosis","volume":"103","author":"O\u2019Brien","year":"2011","journal-title":"Mol Genet Metab"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keu165","article-title":"Rheumatoid arthritis-related interstitial lung disease: Associations, prognostic factors and physiological and radiological characteristics--a large multicentre UK study","volume":"53","author":"Kelly","year":"2014","journal-title":"Rheumatology"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1378\/chest.127.6.2019","article-title":"Histopathologic pattern and clinical features of rheumatoid arthritis-associated interstitial lung disease","volume":"127","author":"Lee","year":"2005","journal-title":"Chest"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1002\/art.42861","article-title":"2023 American College of Rheumatology (ACR)\/American College of Chest Physicians (CHEST) guideline for the treatment of interstitial lung disease in people with systemic autoimmune rheumatic diseases","volume":"76","author":"Johnson","year":"2024","journal-title":"Arthritis Rheumatol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1778211\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T05:27:11Z","timestamp":1777267631000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1778211\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,27]]},"references-count":15,"alternative-id":["10.3389\/fimmu.2026.1778211"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1778211","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,27]]},"article-number":"1778211"}}